Literature DB >> 34189997

Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis.

Chao Yang1, Jiang Shi1, Jie Wang1, Dexun Hao1, Jinlu An1, Junguang Jiang1.   

Abstract

Circular RNAs (circRNAs) are related to the progression of non-small cell lung cancer (NSCLC). However, the roles and mechanism of circ_0006988 are largely unknown. The levels of circ_0006988, Low-Density Lipoprotein Receptor Class A Domain Containing 3 (LDLRAD3), microRNA-491-5p (miR-491-5p), Mitogen-Activated Protein Kinase Kinase Kinase 3 (MAP3K3) were measured using quantitative real-time polymerase-chain reaction (qRT-PCR) and western blot assay. The characteristic of circ_0006988 was analyzed by RNase R assay and Actinomycin D assay. Functional analyses were processed by Cell Counting Kit-8 (CCK-8) assay, 5-ethynyl-2'-deoxyuridine (EdU) assay, colony formation assay, flow cytometry analysis, transwell assay, wound-healing assay and tube formation assay. The interactions between circ_0006988 and miR-491-5p as well as miR-491-5p and MAP3K3 were analyzed by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Murine xenograft model assay was processed to verify the function of circ_0006988 in vivo. Immunohistochemistry (IHC) assay was conducted to examine the level of Ki67. Circ_0006988 abundance was increased in NSCLC tissues and cells. Circ_0006988 silencing restrained NSCLC cell proliferation, migration, invasion and angiogenesis, and induced apoptosis. Circ_0006988 sponged miR-491-5p, which directly targeted MAP3K3. MiR-491-5p overexpression repressed NSCLC cell malignant behaviors. MiR-491-5p downregulation or MAP3K3 overexpression reversed the effect of circ_0006988 silencing on NSCLC cell progression. In addition, circ_0006988 knockdown reduced xenograft tumor growth. ssCirc_0006988 contributed to the development of NSCLC by miR-491-5p/MAP3K3 axis.

Entities:  

Keywords:  MAP3K3; NSCLC; circ_0006988; miR-491-5p

Mesh:

Substances:

Year:  2021        PMID: 34189997      PMCID: PMC8331010          DOI: 10.1080/15384101.2021.1941612

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  32 in total

Review 1.  Circular RNAs function as ceRNAs to regulate and control human cancer progression.

Authors:  Yaxian Zhong; Yajun Du; Xue Yang; Yongzhen Mo; Chunmei Fan; Fang Xiong; Daixi Ren; Xin Ye; Chunwei Li; Yumin Wang; Fang Wei; Can Guo; Xu Wu; Xiaoling Li; Yong Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2018-04-07       Impact factor: 27.401

2.  Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.

Authors:  Shijie Xing; Yue Qu; Chaoyi Li; Ai Huang; Song Tong; Chuangyan Wu; Kai Fan
Journal:  J Cell Physiol       Date:  2019-05-20       Impact factor: 6.384

3.  miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.

Authors:  Wei-Chieh Huang; Shih-Hsuan Chan; Te-Hsuan Jang; Jer-Wei Chang; Ying-Chin Ko; Tzu-Chen Yen; Shang-Lun Chiang; Wei-Fan Chiang; Tien-Yu Shieh; Chun-Ta Liao; Jyh-Lyh Juang; Hsueh-Chun Wang; Ann-Joy Cheng; Ya-Ching Lu; Lu-Hai Wang
Journal:  Cancer Res       Date:  2013-12-12       Impact factor: 12.701

4.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  P E Postmus; K M Kerr; M Oudkerk; S Senan; D A Waller; J Vansteenkiste; C Escriu; S Peters
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976

5.  Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.

Authors:  Sushma Jonna; Deepa S Subramaniam
Journal:  Discov Med       Date:  2019-03       Impact factor: 2.970

6.  Circ_0016760 Acts as a Sponge of MicroRNA-4295 to Enhance E2F Transcription Factor 3 Expression and Facilitates Cell Proliferation and Glycolysis in Non-Small Cell Lung Cancer.

Authors:  Xuebo Yan; Tong Wang; Jiong Wang
Journal:  Cancer Biother Radiopharm       Date:  2020-11-24       Impact factor: 3.099

7.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

8.  Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis.

Authors:  Feng Liu; Hui Zhang; Fei Xie; Dan Tao; Xingyuan Xiao; Chao Huang; Miao Wang; Chaohui Gu; Xiaoping Zhang; Guosong Jiang
Journal:  Oncogene       Date:  2019-11-08       Impact factor: 9.867

Review 9.  Circular RNAs and RNA Splice Variants as Biomarkers for Prognosis and Therapeutic Response in the Liquid Biopsies of Lung Cancer Patients.

Authors:  Florence de Fraipont; Sylvie Gazzeri; William C Cho; Beatrice Eymin
Journal:  Front Genet       Date:  2019-05-07       Impact factor: 4.599

10.  miR‑505 inhibits cell growth and EMT by targeting MAP3K3 through the AKT‑NFκB pathway in NSCLC cells.

Authors:  Huaping Tang; Weihong Lv; Wenxin Sun; Qiaojie Bi; Yueqin Hao
Journal:  Int J Mol Med       Date:  2018-12-31       Impact factor: 4.101

View more
  4 in total

Review 1.  Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer.

Authors:  Javeria Qadir; Feiya Li; Burton B Yang
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

Review 2.  Regulation of apoptosis, autophagy and ferroptosis by non-coding RNAs in metastatic non-small cell lung cancer (Review).

Authors:  Lei Xu; Xin Huang; Yan Lou; Wei Xie; Hangyu Zhao
Journal:  Exp Ther Med       Date:  2022-03-28       Impact factor: 2.447

Review 3.  Non-coding RNAs in lung cancer: emerging regulators of angiogenesis.

Authors:  Yajie Liao; Xudong Wu; Mengyu Wu; Yuan Fang; Jie Li; Weiqiang Tang
Journal:  J Transl Med       Date:  2022-08-02       Impact factor: 8.440

4.  Ursolic acid treats renal tubular epithelial cell damage induced by calcium oxalate monohydrate via inhibiting oxidative stress and inflammation.

Authors:  Zhaohui Jia; Wensheng Li; Pan Bian; Liuyang Yang; Hui Liu; Dong Pan; Zhongling Dou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.